19 results
SC TO-T
EX-99
HRMY
Harmony Biosciences Holdings Inc
28 Aug 23
Third party tender offer statement
8:23am
appeal from, such final court judgment.
(c) EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT
SC TO-C
EX-2.1
ZYNE
Zynerba Pharmaceuticals, Inc.
14 Aug 23
Information about tender offer
5:29pm
equitable relief and other monetary damages, remedies or awards.
(b)EACH OF THE PARTIES TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY … )EACH OF THE PARTIES TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED
SC TO-C
EX-99.1
ZYNE
Zynerba Pharmaceuticals, Inc.
14 Aug 23
Information about tender offer
5:29pm
CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY
8-K
EX-99.1
ZYNE
Zynerba Pharmaceuticals, Inc.
14 Aug 23
Tender and Support Agreement
7:42am
TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT
8-K
EX-2.1
ZYNE
Zynerba Pharmaceuticals, Inc.
14 Aug 23
Tender and Support Agreement
7:42am
and other monetary damages, remedies or awards.
(b) EACH OF THE PARTIES TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER … are not granted
(c) EACH OF THE PARTIES TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY
424B5
wgu21bhql8w5apaset6
21 Jul 22
Prospectus supplement for primary offering
7:36am
424B5
yld0 6r4rd2
12 May 21
Prospectus supplement for primary offering
9:22am
424B5
94uz uzrplnm9uuic
30 Aug 19
Prospectus supplement for primary offering
4:27pm
10-K
l6gpjkz
14 Mar 16
Annual report
12:00am
DRS/A
i2q5 0ibv
20 Feb 15
Draft registration statement (amended)
12:00am
DRS
px84r 1mv
12 Jan 15
Draft registration statement
12:00am
- Prev
- 1
- Next